LD-2 disclosure · 4th Quarter - Report
PERRIGO, INC.
Client
- Name
- PERRIGO, INC.
- Description
- Develop, manufacture, and distribute packaging of OTC & prescription pharmaceuticals.
- Location
- Michigan · United States of America
Registrant
- Description
- Consulting, Lobbying and Government Affairs
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesHealth Issues
Dextromethorphan, Pseudoephedrine restriction issues.
Lobbyistsmr DAVID PATRICK ROBERTSON · THOMAS CRAWFORD
TargetedSENATE · HOUSE OF REPRESENTATIVES
Pharmacy
Repeals a requirement enacted into law as part of the PPACA of 2010 that requires consumers to obtain a prescription in order to utilize their FSA's and HSA's to purchase over-the-counter OTC medicines. FDA's proposed changes to generic drug labeling. "Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018", H.R. 5333. "Over-the-Counter Drug Safety, Innovation, and Reform Act", S. 2315.
Lobbyistsmr DAVID PATRICK ROBERTSON · THOMAS CRAWFORD · SCOTT STYLES
TargetedSENATE · HOUSE OF REPRESENTATIVES
Taxation/Internal Revenue Code
Monitor issues as they relate to the implementation of tax reform.
Lobbyistsmr DAVID PATRICK ROBERTSON · THOMAS CRAWFORD · SCOTT STYLES · KYLE CORMNEY
TargetedSENATE · HOUSE OF REPRESENTATIVES